Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study (Q46192023)
Jump to navigation
Jump to search
scientific article published on 5 November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study |
scientific article published on 5 November 2008 |
Statements
1 reference
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study (English)
1 reference
1 reference
Pierre Fenaux
1 reference
Lionel Adès
1 reference
Simone Boehrer
1 reference
Odile Beyne-Rauzy
1 reference
Laurence Legros
1 reference
Christophe Ravoet
1 reference
François Dreyfus
1 reference
Aspasia Stamatoullas
1 reference
Marie Pierre Chaury
1 reference
Jacques Delaunay
1 reference
Guy Laurent
1 reference
Norbert Vey
1 reference
Sara Burcheri
1 reference
Rose-Marie Mbida
1 reference
Natacha Hoarau
1 reference
Claude Gardin
1 reference
5 November 2008
1 reference
1 reference
113
1 reference
17
1 reference
3947-3952
1 reference